RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Mauna Kea Technologies Stock

Mauna Kea Technologies Equity 2024

Mauna Kea Technologies Equity

-17.28 M EUR

Ticker

ALMKT.PA

ISIN

FR0010609263

WKN

A1JCLA

In 2024, Mauna Kea Technologies's equity was -17.28 M EUR, a -13.27% increase from the -19.92 M EUR equity in the previous year.

Mauna Kea Technologies Aktienanalyse

What does Mauna Kea Technologies do?

Mauna Kea Technologies is a French company specializing in the development of medical devices. The company was founded in 2000 by Sacha Loiseau, who still leads the company today. The goal of Mauna Kea Technologies is to use state-of-the-art technology to improve the diagnosis and treatment of patients in medicine. The business model of Mauna Kea Technologies is based on the development and sale of products used in the diagnosis and treatment of patients. Mauna Kea Technologies' products are based on confocal microscopy, a technology that allows for significant magnification and examination of tissue and cell structures. The technology is used in various areas of medicine, such as gastroenterology, hepatology, pulmonology, and oncology. Mauna Kea Technologies is divided into different divisions to meet the requirements of different areas of medicine. The first division is Cellvizio, a confocal microscope used in endoscopy. Cellvizio allows doctors to see real-time images, enabling quick and accurate diagnosis. The second division is Lumicell, used in surgery. Lumicell allows surgeons to detect and remove cancer cells in real time, enabling a more precise operation. The third division is Orally, a device used in dentistry. Orally is a mobile confocal microscope that allows dentists to detect microorganisms in real time and obtain a more accurate picture of their patients' oral health. The fourth division is Pediatric, a confocal microscope specifically designed for pediatrics. It allows doctors to see images that are 10 times larger than traditional medical devices. Mauna Kea Technologies is a leading provider of medical devices based on confocal microscopy. The company has already partnered with some of the leading medical institutions worldwide to promote the use of its products in the diagnosis and treatment of patients. Mauna Kea Technologies has also received awards for its products and excellent research and development, including the CES Innovation Award, the World Economic Forum Technology Pioneer Award, and the Galien Medical Award. Mauna Kea Technologies' products have the potential to revolutionize the way diseases are diagnosed and treated. Confocal microscopy allows doctors to obtain high-resolution images and detect diseases at a much earlier stage than traditional medical devices. With its products, the company has already saved countless lives and contributed to improving the quality of medical care. In summary, Mauna Kea Technologies is an innovative and leading company in the medical technology industry. With its state-of-the-art products and the use of confocal microscopy, the company has revolutionized the way diseases are diagnosed and treated. Mauna Kea Technologies will continue to be a key player in the medical technology industry in the future and will undoubtedly continue to contribute to improving global healthcare. Mauna Kea Technologies ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Mauna Kea Technologies's Equity

Mauna Kea Technologies's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Mauna Kea Technologies's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Mauna Kea Technologies's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Mauna Kea Technologies's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Mauna Kea Technologies’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Mauna Kea Technologies stock

What is the equity of Mauna Kea Technologies this year?

Mauna Kea Technologies has equity of -17.28 M EUR this year.

What was the equity of Mauna Kea Technologies compared to the previous year?

The equity of Mauna Kea Technologies has increased/decreased by -13.27% decreased compared to the previous year.

What impact does a high equity have on investors of Mauna Kea Technologies?

A high equity is advantageous for investors of Mauna Kea Technologies as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Mauna Kea Technologies?

A low equity can be a risk for investors of Mauna Kea Technologies, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Mauna Kea Technologies affect the company?

An increase in equity of Mauna Kea Technologies can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Mauna Kea Technologies affect the company?

A reduction in equity of Mauna Kea Technologies can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Mauna Kea Technologies?

Some factors that can affect the equity of Mauna Kea Technologies include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Mauna Kea Technologies so important for investors?

The equity of Mauna Kea Technologies is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Mauna Kea Technologies take to change the equity?

To change equity, Mauna Kea Technologies can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Mauna Kea Technologies pay?

Over the past 12 months, Mauna Kea Technologies paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Mauna Kea Technologies is expected to pay a dividend of 0 EUR.

What is the dividend yield of Mauna Kea Technologies?

The current dividend yield of Mauna Kea Technologies is .

When does Mauna Kea Technologies pay dividends?

Mauna Kea Technologies pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Mauna Kea Technologies?

Mauna Kea Technologies paid dividends every year for the past 0 years.

What is the dividend of Mauna Kea Technologies?

For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.

In which sector is Mauna Kea Technologies located?

Mauna Kea Technologies is assigned to the 'Health' sector.

Wann musste ich die Aktien von Mauna Kea Technologies kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Mauna Kea Technologies from 9/29/2024 amounting to 0 EUR, you needed to have the stock in your portfolio before the ex-date on 9/29/2024.

When did Mauna Kea Technologies pay the last dividend?

The last dividend was paid out on 9/29/2024.

What was the dividend of Mauna Kea Technologies in the year 2023?

In the year 2023, Mauna Kea Technologies distributed 0 EUR as dividends.

In which currency does Mauna Kea Technologies pay out the dividend?

The dividends of Mauna Kea Technologies are distributed in EUR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Mauna Kea Technologies

Our stock analysis for Mauna Kea Technologies Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Mauna Kea Technologies Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.